Erratum to: Characterization of circulating microparticle-associated CD39 family ecto-nucleotidases in human plasma [Purinergic Signalling, 10.1007/s11302-014-9423-6];Characterization of circulating microparticle-associated CD39 family ecto-nucleotidases in human plasma

Purinergic Signalling

Volumn 10, Issue 4, 2014, Pages 611-618

  Jiang, Z Gordon ^a,b   Wu, Yan ^a,b   Csizmadia, Eva ^a,b   Feldbrügge, Linda ^a,b,c   Enjyoji, Keiichi ^a,b   Tigges, John ^a,b   Toxavidis, Vasilis ^a,b   Stephan, Holger ^d   Müller, Christina E ^e   McKnight, C James ^f   Moss, Alan ^a,b   Robson, Simon C ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^d INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

^e UNIVERSITY OF BONN   (Germany)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine; ADP; ATP; CD39; Ecto nucleotidase; Purinergic signaling; TLC

Indexed keywords

CD39 ANTIGEN; ECTO 5' NUCLEOTIDASE; ADENOSINE DIPHOSPHATE; APYRASE; LEUKOCYTE ANTIGEN;

ARTICLE; BLOOD CELL; ELECTROPHORESIS; FLOW CYTOMETRY; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; MOLECULAR MODEL; NORMAL HUMAN; NUCLEOTIDE METABOLISM; PHLEBOTOMY; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; THIN LAYER CHROMATOGRAPHY; WESTERN BLOTTING; ENZYMOLOGY; MEMBRANE MICROPARTICLE; METABOLISM; SIZE EXCLUSION CHROMATOGRAPHY;

ADENOSINE DIPHOSPHATE; ANTIGENS, CD; APYRASE; BLOTTING, WESTERN; CELL-DERIVED MICROPARTICLES; CHROMATOGRAPHY, GEL; FLOW CYTOMETRY; HUMANS;

EID: 84919832543     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-014-9429-0     Document Type: Erratum

References (38)

1. Eltzschig HK, Sitkovsky MV, Robson SC (2012) Purinergic signaling during inflammation. N Engl J Med 367:2322–2333
2. Longhi MS, Robson SC, Bernstein SH, Serra S, Deaglio S (2013) Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states. J Mol Med (Berlin) 91:165–172
3. Deaglio S, Robson SC (2011) Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity. Adv Pharmacol 61:301–332
4. Jacob F, Perez Novo C, Bachert C, Van Crombruggen K (2013) Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses. Purinergic Signal 9:285–306
5. Jorgensen S (1956) Breakdown of adenine and hypoxanthine nucleotides and nucleosides in human plasma. Acta Pharmacol Toxicol (Copenh) 12:294–302
6. Coade SB, Pearson JD (1989) Metabolism of adenine nucleotides in human blood. Circ Res 65:531–537
7. Yegutkin GG, Samburski SS, Jalkanen S (2003) Soluble purine-converting enzymes circulate in human blood and regulate extracellular ATP level via counteracting pyrophosphatase and phosphotransfer reactions. FASEB J 17:1328–1330
8. Yegutkin GG, Wieringa B, Robson SC, Jalkanen S (2012) Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1/CD39 activities. FASEB J 26:3875–3883
9. Robson SC, Sevigny J, Zimmermann H (2006) The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal 2:409–430
10. Zimmermann H, Zebisch M, Strater N (2012) Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signal 8:437–502
11. Eckle T, Fullbier L, Wehrmann M, Khoury J, Mittelbronn M et al (2007) Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J Immunol 178:8127–8137
12. Colgan SP, Eltzschig HK (2012) Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery. Annu Rev Physiol 74:153–175
13. Friedman DJ, Kunzli BM, YI AR, Sevigny J, Berberat PO et al (2009) From the cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc Natl Acad Sci U S A 106:16788–16793
14. Friedman DJ, Talbert ME, Bowden DW, Freedman BI, Mukanya Y et al (2009) Functional ENTPD1 polymorphisms in African Americans with diabetes and end-stage renal disease. Diabetes 58:999–1006
15. Eltzschig HK, Eckle T (2011) Ischemia and reperfusion—from mechanism to translation. Nat Med 17:1391–1401
16. Banz Y, Beldi G, Wu Y, Atkinson B, Usheva A et al (2008) CD39 is incorporated into plasma microparticles where it maintains functional properties and impacts endothelial activation. Br J Haematol 142:627–637
17. ELA S, Mager I, Breakefield XO, Wood MJ (2013) Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov 12:347–357
18. Schmelzle M, Splith K, Andersen LW, Kornek M, Schuppan D et al (2013) Increased plasma levels of microparticles expressing CD39 and CD133 in acute liver injury. Transplantation 95:63–69
19. Visovatti SH, Hyman MC, Bouis D, Neubig R, McLaughlin VV et al (2012) Increased CD39 nucleotidase activity on microparticles from patients with idiopathic pulmonary arterial hypertension. PLoS One 7:e40829
20. Muller CE, Iqbal J, Baqi Y, Zimmermann H, Rollich A et al (2006) Polyoxometalates—a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors. Bioorg Med Chem Lett 16:5943–5947
21. Wu Y, Sun X, Kaczmarek E, Dwyer KM, Bianchi E et al (2006) RanBPM associates with CD39 and modulates ecto-nucleotidase activity. Biochem J 396:23–30
22. Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671–675
23. Kornek M, Popov Y, Libermann TA, Afdhal NH, Schuppan D (2011) Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells. Hepatology 53:230–242
24. Yuana Y, Bertina RM, Osanto S (2011) Pre-analytical and analytical issues in the analysis of blood microparticles. Thromb Haemost 105:396–408
25. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680
26. Arnold K, Bordoli L, Kopp J, Schwede T (2006) The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22:195–201
27. Zebisch M, Krauss M, Schafer P, Strater N (2012) Crystallographic evidence for a domain motion in rat nucleoside triphosphate diphosphohydrolase (NTPDase) 1. J Mol Biol 415:288–306
28. Glaser F, Pupko T, Paz I, Bell RE, Bechor-Shental D et al (2003) ConSurf: identification of functional regions in proteins by surface-mapping of phylogenetic information. Bioinformatics 19:163–164
29. Stout JG, Kirley TL (1996) Control of cell membrane ecto-ATPase by oligomerization state: intermolecular cross-linking modulates ATPase activity. Biochemistry 35:8289–8298
30. Schulte am Esch J 2nd, Sevigny J, Kaczmarek E, Siegel JB, Imai M et al (1999) Structural elements and limited proteolysis of CD39 influence ATP diphosphohydrolase activity. Biochemistry 38:2248–2258
31. Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K et al (2010) Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 28:1248–1250
32. Fausther M, Lecka J, Soliman E, Kauffenstein G, Pelletier J et al (2012) Coexpression of ecto-5′-nucleotidase/CD73 with specific NTPDases differentially regulates adenosine formation in the rat liver. Am J Physiol Gastrointest Liver Physiol 302:G447–459
33. Panayiotou C, Solaroli N, Karlsson A (2014) The many isoforms of human adenylate kinases. Int J Biochem Cell Biol 49C:75–83
34. Dzeja PP, Chung S, Terzic A (2007) In: Saks V (ed) Molecular system bioenergetics. Wiley-VCH, Weinheim
35. Choo HJ, Kim BW, Kwon OB, Lee CS, Choi JS et al (2008) Secretion of adenylate kinase 1 is required for extracellular ATP synthesis in C2C12 myotubes. Exp Mol Med 40:220–228
36. Orru V, Steri M, Sole G, Sidore C, Virdis F et al (2013) Genetic variants regulating immune cell levels in health and disease. Cell 155:242–256
37. Andrade CM, Wink MR, Margis R, Borojevic R, Battastini AM et al (2010) Changes in E-NTPDase 3 expression and extracellular nucleotide hydrolysis during the myofibroblast/lipocyte differentiation. Mol Cell Biochem 339:79–87
38. Fausther M, Lecka J, Kukulski F, Levesque SA, Pelletier J et al (2007) Cloning, purification, and identification of the liver canalicular ecto-ATPase as NTPDase8. Am J Physiol Gastrointest Liver Physiol 292:G785–795